Specifically, Mayo Clinic researchers found fellowship-trained surgeons who practice in academic medical centers with high volumes of patients with kidney tumors were 70-80 percent more likely to follow American Urological Association guidelines by recommending partial nephrectomy. Surgeons in private practice who see few patients with kidney tumors more often offered radical nephrectomy: removal of the entire kidney.
The study shows that as kidney tumors get larger and more complex, all surgeons tend to offer a radical nephrectomy. However, the tumor complexity that may result in one surgeon recommending total removal of the kidney may be well below a more experienced surgeon’s threshold.
Read the Mayo Clinic news release about management of small kidney tumors.
Related Articles on the Mayo Clinic:
Mayo, Geisinger, Cleveland Clinic May Not Participate in ACOs
Study: Robotic Surgery Effective for Hard-to-Reach Larynx Cancer
Florida’s Mayo Clinic Receives $1.7M Gift to Help Build Education Simulation Center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
